Clinical Trial Update: Adjuvant Palbociclib in Elderly Patients With Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating adjuvant palbociclib in elderly patients with stage II-III breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Breast Cancer Stage II, Breast Cancer Stage III | Phase 2 | Status: ACTIVE_NOT_RECRUITING